Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.

about

Combinatorial immunotherapy for melanoma.Dendritic cell therapy in melanoma.Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.

P2860

Q39005199-2253F3CD-A700-4027-B45F-CED2E701E46A Q43923587-92C212CE-67B5-47FA-B31A-1FE0D22AA292 Q53159624-B9EBB580-4364-4D15-824C-F6EFD8BDD7B1

P2860

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.

Item

http://www.wikidata.org/entity/Q36885544

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment patterns of adjuvant ...... nar de Melanoma - Prima study.

@en

type

Item

label

Treatment patterns of adjuvant ...... nar de Melanoma - Prima study.

@en

prefLabel

Treatment patterns of adjuvant ...... nar de Melanoma - Prima study.

@en

P1476

Treatment patterns of adjuvant ...... nar de Melanoma - Prima study.

@en

P2093

Ainara Soria

http://www.w3.org/2001/XMLSchema#string

Alfonso Berrocal

http://www.w3.org/2001/XMLSchema#string

Ana Ballesteros

http://www.w3.org/2001/XMLSchema#string

Elia Samaniego

http://www.w3.org/2001/XMLSchema#string

Enrique Espinosa

http://www.w3.org/2001/XMLSchema#string

Guillermo López-Vivanco

http://www.w3.org/2001/XMLSchema#string

Isabel Palacio

http://www.w3.org/2001/XMLSchema#string

Kendall Stevinson

http://www.w3.org/2001/XMLSchema#string

Lorenzo Alonso

http://www.w3.org/2001/XMLSchema#string

Luis de la Cruz-Merino

http://www.w3.org/2001/XMLSchema#string

P2860

Patient preferences for adjuvant interferon alfa-2b treatment.

Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Adjuvant therapy of cutaneous melanoma: the interferon debate.

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma.

Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.

P304

278-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CMR.0000000000000254

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26958991

http://www.w3.org/2001/XMLSchema#string

P932

4861701

http://www.w3.org/2001/XMLSchema#string

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.

about

P2860

P2860

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932